The newly formed medtech alliance comprised of Kinetic Concepts, LifeCell and Systagenix posted collective figures that put the group in the red for Q4, a recent SEC filing shows.
Merged in September 2013, the wound care, biologics and regenerative medicines giant posted losses of $52.7 million on sales of $469.8 million for the 3 months ended December 31. That compared with earnings of $39.7 million on sales of $439.9 million during the same period in 2012.
Adjusted Q4 2013 EBITDA amounted to $191.9 million, according to filings, compared with $193 million in Q4 of 2012.
The trio also posted nearly tripled losses for the full year, with $558.7 million in losses on sales of $1.76 billion for 2013. That compared with losses of $141.4 million on sales of $1.75 billion in 2012.
The figures were posted by Centaur Guernsey, a non-operating holding company comprised of Kinetic Concepts and LifeCell and controlled by investment groups.
Kinetic Concepts went private in 2011 thanks to a $6.3 billion acquisition by investment firm Apax Partners and a pair of Canadian pension funds. The company dropped $485 million on wound care company Systagenix and shortly after joined forces with LifeCell Corp.
